Format

Send to

Choose Destination
See comment in PubMed Commons below
J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):933-8. doi: 10.1016/j.jmig.2016.05.008. Epub 2016 May 28.

Total Laparoscopic (S-LPS) versus TELELAP ALF-X Robotic-Assisted Hysterectomy: A Case-Control Study.

Author information

  • 1Department of Medicine and Aging Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy. Electronic address: francesco.fanfani@unich.it.
  • 2Department of Obstetrics and Gynecology, University of Trieste, Trieste, Italy.
  • 3Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy.

Abstract

STUDY OBJECTIVE:

To compare the feasibility and safety of the TELELAP ALF-X system and standard laparoscopy for total hysterectomy to treat patients with benign and early malignant gynecologic disease.

DESIGN:

Single-institution retrospective case-control study (Canadian Task Force classification II-2).

SETTING:

Catholic University of the Sacred Heart, Rome, Italy.

PATIENTS:

Between October 2013 and May 2015, 203 women underwent TELELAP-ALF X (group 1) or standard laparoscopic (group 2) total hysterectomy and were enrolled.

INTERVENTIONS:

Total standard laparoscopy vs TELELAP ALF-X robot-assisted hysterectomy for benign and early malignant gynecologic disease.

MEASUREMENTS AND MAIN RESULTS:

In group 1, the median age was 55 years (range, 40-79 years), median body mass index (BMI) was 25 kg/m(2) (range, 17-38 kg/m(2)), and 51 patients (58%) had undergone previous abdominal surgery. In the control group, the median age was 55 years (range, 34-90 years), median BMI was 25 kg/m(2) (range, 17-41 kg/m(2)), and 31 patients (27%) had previous abdominal surgery. The median operative time was 147 minutes (range, 58-320 minutes) in group 1 and 80 minutes (range, 22-300 minutes) in group 2 (p = .055). The median estimated blood loss was 57 mL (range, 0-600 mL) in group 1 and 99 mL (range, 0-400 mL) in group 2, with no significant differences between the 2 groups (p = .963). Procedures were successfully performed without conversion in 94.3% of cases in the group 1 and in all cases in group 2. Early postoperative pain was significantly lower in group 2.

CONCLUSION:

TELELAP ALF-X hysterectomy in patients with benign and early malignant gynecologic disease is feasible and safe, and can be considered a valid option for these patients.

KEYWORDS:

Hysterectomy; Laparoscopy; Robotic; TELELAP ALF-X

PMID:
27247263
DOI:
10.1016/j.jmig.2016.05.008
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center